Feedback

EU threatens AstraZeneca with legal action over vaccine supply delays

Source : 112 Ukraine

Von der Leyen also announced that Brussels intends to create a mechanism to control the export of vaccines outside the EU
11:21, 27 January 2021

AFP

Due to vaccine supply delays, the European Union has stepped up pressure on the British-Swedish  pharmaceutical company AstraZeneca. EU states are considering ­suing AstraZeneca for breach of contract. This was announced on January 26 by Latvian Foreign Minister Edgars Rinkevics, DW reports.

Related: Moderna starts clinical trials of new vaccine against Covid-19 mutations

“We still hope that they will honor commitments, however all options are on the table,” the head of the country's foreign affairs agency said.

At the same time, European Commission President Ursula von der Leyen at the World Economic Forum in Davos called on vaccine manufacturers that have signed contracts with the EU to fulfill their obligations. According to her, Europe has contributed billions of dollars to the development of drugs from SARS-CoV-2 "and now the companies must fulfill their obligations and supply vaccines." Von der Leyen also announced that Brussels intends to create a mechanism to control the export of vaccines outside the EU.

Related: WHO: Poorer nations to get first 40 million vaccines next month

Meanwhile, AstraZeneca is to cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems. 

Officials have not confirmed publicly how big the shortfall will be, but an unnamed EU official said that deliveries would be reduced to 31m - a cut of 60% - in the first quarter of this year.

The drug firm had been set to deliver about 80 million doses to the 27 nations by March.

Related: EU puts more pressure on manufacturers of Covid-19 vaccines amid delays in supply

 

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more